千金药业业绩快报：2025年归母净利润2.88亿元，同比增长24.74%

Group 1 - The company reported a total operating revenue of 3.635 billion yuan for the fiscal year 2025, representing a year-on-year growth of 0.13% [1] - The net profit attributable to shareholders of the listed company was 288 million yuan, showing a year-on-year increase of 24.74% [1] - The basic earnings per share were 0.6414 yuan [1]